Aclarion (ACON) News Today $0.20 -0.02 (-9.09%) (As of 12/29/2023 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAclarion, Inc. (NASDAQ:ACON) Short Interest Updateamericanbankingnews.com - December 30 at 3:22 AMAclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Examsfinance.yahoo.com - November 27 at 8:55 AMAclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoptionfinance.yahoo.com - November 9 at 9:56 AMAclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MDmarkets.businessinsider.com - November 6 at 8:38 AMAclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denverfinance.yahoo.com - October 25 at 8:50 AMAclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meetingfinance.yahoo.com - October 24 at 9:09 AMAclarion Provides Updated Investor Presentation and Corporate Updatefinance.yahoo.com - October 2 at 9:01 AMAclarion Inc.barrons.com - September 8 at 5:45 AMAclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Reportfinance.yahoo.com - August 25 at 6:56 PMAclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MIfinance.yahoo.com - June 14 at 3:59 PMWhy Aclarion Stock Is Popping Todaybenzinga.com - June 8 at 6:09 PMACON Skyrockets after Presentation of Nociscan Abstractmsn.com - June 8 at 1:08 PMAclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meetingfinance.yahoo.com - June 8 at 8:07 AMAclarion Announces New Engagement with The London Clinic and London Spine Clinicfinance.yahoo.com - May 30 at 10:03 AMAclarion, Inc. Announces Delayed 10-Q Filingfinance.yahoo.com - May 23 at 9:54 AMAclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MDfinance.yahoo.com - May 23 at 9:54 AMAclarion gets $2M debt financingmsn.com - May 19 at 9:31 AMAclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalystsfinance.yahoo.com - May 19 at 9:31 AMAclarion providing less invasive solution to treat lo back pain through augmented intelligenceproactiveinvestors.com - May 10 at 1:42 PMAclarion to Host Thought Leadership Symposium at SPINEWEEK 2023finance.yahoo.com - April 28 at 4:34 PMAclarion, Inc. (ACON) Interactive Stock Chart - Yahoo Financeca.finance.yahoo.com - April 24 at 4:16 PMmarketbeat.com - April 24 at 3:28 PMmarketbeat.com - April 24 at 12:35 PMmarketbeat.com - April 24 at 11:06 AMmarketbeat.com - April 24 at 10:28 AMmarketbeat.com - April 24 at 10:22 AMmarketbeat.com - April 24 at 10:11 AMmarketbeat.com - April 24 at 10:05 AMmarketbeat.com - April 24 at 9:52 AMmarketbeat.com - April 24 at 9:46 AMmarketbeat.com - April 24 at 9:40 AMAclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trialfinance.yahoo.com - April 24 at 9:25 AMWhy Aclarion Shares Are Soaring Todaybenzinga.com - April 24 at 9:25 AMAclarion Surges on Promising Nociscan Data in DLBPmsn.com - April 24 at 9:25 AMAclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisorfinance.yahoo.com - March 7 at 7:01 PMAclarion to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th, 2023finance.yahoo.com - February 16 at 8:02 AMAclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposiumfinance.yahoo.com - February 15 at 9:55 AMInsiders who bought stock earlier this year lose -US$213k as Aclarion, Inc. (NASDAQ:ACON) drops to US$4.7mfinance.yahoo.com - February 5 at 11:19 AMGregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisorfinance.yahoo.com - January 31 at 2:03 PMThe Investor Summit: Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Eventfinanznachrichten.de - January 17 at 11:21 AMAclarion to Present at the Jan 26th Virtual Investor Summit Microcap Eventfinance.yahoo.com - January 17 at 11:21 AMAclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisorfinance.yahoo.com - January 17 at 11:21 AMDr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisorfinance.yahoo.com - December 22 at 12:24 PMAclarion’s Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MDfinance.yahoo.com - December 21 at 2:58 PMAclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisorfinance.yahoo.com - December 19 at 9:46 AMAclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator Biomarkerfinance.yahoo.com - December 1 at 4:02 PMACON.OQ - Aclarion Inc | Stock Price & Latest News | Reutersreuters.com - November 30 at 3:53 PMAclarion Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - November 16 at 5:38 AMAclarion, Inc. Releases Updated Investor Presentation In Connection with Appearance at LD Micro Main Event XVfinance.yahoo.com - October 25 at 10:38 AMDr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisorfinance.yahoo.com - October 24 at 9:12 AM Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address ACON Media Mentions By Week ACON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACON News Sentiment▼1.280.84▲Average Medical News Sentiment ACON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACON Articles This Week▼30▲ACON Articles Average Week Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OpGen News Today Tivic Health Systems News Today NeuBase Therapeutics News Today Comera Life Sciences News Today ZIVO Bioscience News Today Salarius Pharmaceuticals News Today NantHealth News Today PolyPid News Today Peak Bio News Today Sonnet BioTherapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ACON) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.